首页 > 最新文献

Tissue Engineering Part A最新文献

英文 中文
Hydroxypropyl Chitosan/Soy Protein Isolate Conduits Promote Peripheral Nerve Regeneration. 羟丙基壳聚糖/大豆分离蛋白导管促进周围神经再生。
IF 4.1 Pub Date : 2022-03-01 Epub Date: 2021-10-28 DOI: 10.1089/ten.TEA.2021.0068
Yanan Zhao, Chuan Tian, Ping Wu, Feixiang Chen, Ao Xiao, Qifa Ye, Xiaowen Shi, Zijian Wang, Xinwei Han, Yun Chen

Designing scaffolds, with optimized microstructure and function for promoting the release of neuro-related factors, is significant in peripheral nerve regeneration. Herein, a series of hydroxypropyl chitosan/soy protein isolate composite sponges (HCSS) were fabricated by a freeze-drying technique. The physicochemical properties of the resultant HCSS were examined by a Fourier infrared spectrometer, X-ray diffractometer, scanning electron microscope, water absorption assay, water retention assay, and compressive strength assay. The results indicated that HCSS exhibited an interconnected porous microstructure and a high water retention ratio with the increase in soy protein isolate (SPI) content. The biological characterization found that the HCSS-50 containing 50% SPI content profoundly promoted the proliferation of RSC96 cells and the secretion of neuro-related factors without excessive reactive oxygen species production. In addition, HCSS-50 could significantly promote the expression of neuro-related factors; for example, the expression of TGF-β was three times higher than that of the control group. Finally, an optimized HCSS-based conduit was fabricated from HCSS-50 to repair sciatic nerve injury in rats with the combination of bone marrow mesenchymal stem cells (BMSCs) or BMSC-derived Schwann cells (SCs). The results suggested that the constructed HCSS-based conduit accompanying BMSC-derived SCs could effectively promote axonal regeneration and upregulate the expression of neuro-related factors such as Krox20, Zeb2, and GAP43. Collectively, a newly engineered nerve conduit system was developed by incorporating HCSS-50 and BMSC-derived SCs, which could be an alternative candidate for peripheral nerve regeneration. Impact statement Peripheral nerve repair is of paramount significance in the clinical. This work describes a hydroxypropyl chitosan/soy protein isolate conduit, which could effectively promote axonal regeneration and upregulate the expression of neuro-related factors. Thus, we provide a potential candidate for peripheral nerve regeneration.

设计具有优化结构和促进神经相关因子释放功能的支架,对周围神经再生具有重要意义。采用冷冻干燥技术制备了羟丙基壳聚糖/大豆分离蛋白复合海绵(HCSS)。通过傅里叶红外光谱仪、x射线衍射仪、扫描电子显微镜、吸水率、保水率和抗压强度测试对所得HCSS的理化性质进行了检测。结果表明,随着大豆分离蛋白(SPI)含量的增加,HCSS具有连通的多孔结构和较高的保水率。生物学鉴定发现,含有50% SPI含量的HCSS-50能深刻促进RSC96细胞的增殖和神经相关因子的分泌,而不会产生过多的活性氧。此外,HCSS-50能显著促进神经相关因子的表达;例如,TGF-β的表达比对照组高3倍。最后,以HCSS-50为材料,构建优化后的HCSS-50血管导管,结合骨髓间充质干细胞(BMSCs)或骨髓间充质干细胞衍生的雪旺细胞(SCs)修复大鼠坐骨神经损伤。结果表明,伴随bmscs构建的hcs -based导管可有效促进轴突再生,上调Krox20、Zeb2、GAP43等神经相关因子的表达。总之,将HCSS-50和bmsc衍生的SCs结合在一起,开发了一种新的工程神经导管系统,这可能是周围神经再生的替代候选材料。周围神经修复在临床上具有至关重要的意义。本工作描述了一种羟丙基壳聚糖/大豆分离蛋白通道,它可以有效地促进轴突再生和上调神经相关因子的表达。因此,我们为周围神经再生提供了一个潜在的候选材料。
{"title":"Hydroxypropyl Chitosan/Soy Protein Isolate Conduits Promote Peripheral Nerve Regeneration.","authors":"Yanan Zhao,&nbsp;Chuan Tian,&nbsp;Ping Wu,&nbsp;Feixiang Chen,&nbsp;Ao Xiao,&nbsp;Qifa Ye,&nbsp;Xiaowen Shi,&nbsp;Zijian Wang,&nbsp;Xinwei Han,&nbsp;Yun Chen","doi":"10.1089/ten.TEA.2021.0068","DOIUrl":"https://doi.org/10.1089/ten.TEA.2021.0068","url":null,"abstract":"<p><p>Designing scaffolds, with optimized microstructure and function for promoting the release of neuro-related factors, is significant in peripheral nerve regeneration. Herein, a series of hydroxypropyl chitosan/soy protein isolate composite sponges (HCSS) were fabricated by a freeze-drying technique. The physicochemical properties of the resultant HCSS were examined by a Fourier infrared spectrometer, X-ray diffractometer, scanning electron microscope, water absorption assay, water retention assay, and compressive strength assay. The results indicated that HCSS exhibited an interconnected porous microstructure and a high water retention ratio with the increase in soy protein isolate (SPI) content. The biological characterization found that the HCSS-50 containing 50% SPI content profoundly promoted the proliferation of RSC96 cells and the secretion of neuro-related factors without excessive reactive oxygen species production. In addition, HCSS-50 could significantly promote the expression of neuro-related factors; for example, the expression of TGF-β was three times higher than that of the control group. Finally, an optimized HCSS-based conduit was fabricated from HCSS-50 to repair sciatic nerve injury in rats with the combination of bone marrow mesenchymal stem cells (BMSCs) or BMSC-derived Schwann cells (SCs). The results suggested that the constructed HCSS-based conduit accompanying BMSC-derived SCs could effectively promote axonal regeneration and upregulate the expression of neuro-related factors such as <i>Krox20</i>, <i>Zeb2</i>, and <i>GAP43</i>. Collectively, a newly engineered nerve conduit system was developed by incorporating HCSS-50 and BMSC-derived SCs, which could be an alternative candidate for peripheral nerve regeneration. Impact statement Peripheral nerve repair is of paramount significance in the clinical. This work describes a hydroxypropyl chitosan/soy protein isolate conduit, which could effectively promote axonal regeneration and upregulate the expression of neuro-related factors. Thus, we provide a potential candidate for peripheral nerve regeneration.</p>","PeriodicalId":23133,"journal":{"name":"Tissue Engineering Part A","volume":" ","pages":"225-238"},"PeriodicalIF":4.1,"publicationDate":"2022-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39299680","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Extracellular Matrix Hydrogels Promote Expression of Muscle-Tendon Junction Proteins. 细胞外基质水凝胶促进肌肉肌腱连接蛋白的表达。
IF 4.1 Pub Date : 2022-03-01 Epub Date: 2021-11-02 DOI: 10.1089/ten.TEA.2021.0070
Lewis S Gaffney, Zachary G Davis, Camilo Mora-Navarro, Matthew B Fisher, Donald O Freytes

Muscle and tendon injuries are prevalent and range from minor sprains and strains to traumatic, debilitating injuries. However, the interactions between these tissues during injury and recovery remain unclear. Three-dimensional tissue models that incorporate both tissues and a physiologically relevant junction between muscle and tendon may help understand how the two tissues interact. Here, we use tissue specific extracellular matrix (ECM) derived from muscle and tendon to determine how cells of each tissue interact with the microenvironment of the opposite tissue, resulting in junction-specific features. The ECM materials were derived from the Achilles tendon and gastrocnemius muscle, decellularized, and processed to form tissue-specific pre-hydrogel digests. The ECM materials were unique in respect to protein composition and included many types of ECM proteins, not just collagens. After digestion and gelation, ECM hydrogels had similar complex viscosities that were less than type I collagen hydrogels at the same concentration. C2C12 myoblasts and tendon fibroblasts were cultured in tissue-specific ECM conditioned media or encapsulated in tissue-specific ECM hydrogels to determine cell-matrix interactions and the effects on a muscle-tendon junction marker, paxillin. The ECM conditioned media had only a minor effect on the upregulation of paxillin in cells cultured in monolayer. However, cells cultured within ECM hydrogels had 50-70% higher paxillin expression than cells cultured in type I collagen hydrogels. Contraction of the ECM hydrogels varied by the type of ECM used. Subsequent experiments with a varying density of type I collagen (and thus contraction) showed no correlation between paxillin expression and the amount of gel contraction, suggesting that a constituent of the ECM was the driver of paxillin expression in the ECM hydrogels. In addition, another junction marker, type XXII collagen, had similar expression patterns as paxillin, with smaller effect sizes. Using tissue-specific ECM allowed for the de-construction of the cell-matrix interactions similar to muscle-tendon junctions to study the expression of myotendinous junction-specific proteins. Impact statement The muscle-tendon junction is an important feature of muscle-tendon units; however, despite crosstalk between the two tissue types, the junction is often overlooked in current research. Deconstructing the cell-matrix interactions will provide the opportunity to study significant junction-specific features and markers that should be included in tissue models of the muscle-tendon unit, while gaining a deeper understanding of the natural junction. This research aims at informing future methods to engineer a more relevant multi-tissue platform to study the muscle-tendon unit.

肌肉和肌腱损伤很普遍,范围从轻微的扭伤和拉伤到创伤性的、使人衰弱的损伤。然而,这些组织在损伤和恢复过程中的相互作用仍不清楚。将这两种组织和肌肉和肌腱之间的生理相关连接结合起来的三维组织模型可能有助于理解这两种组织是如何相互作用的。在这里,我们使用来自肌肉和肌腱的组织特异性细胞外基质(ECM)来确定每个组织的细胞如何与相反组织的微环境相互作用,从而产生连接特异性特征。ECM材料来源于跟腱和腓肠肌,经过脱细胞处理,形成组织特异性的预水凝胶消化。ECM材料在蛋白质组成方面是独特的,包括许多类型的ECM蛋白,而不仅仅是胶原蛋白。经消化和凝胶化后,ECM水凝胶具有相似的复合粘度,且在相同浓度下低于I型胶原水凝胶。C2C12成肌细胞和肌腱成纤维细胞在组织特异性ECM条件培养基中培养或包被在组织特异性ECM水凝胶中,以测定细胞-基质相互作用和对肌肉-肌腱连接标记物paxillin的影响。在单层培养的细胞中,ECM条件培养基对paxillin的上调只有轻微的影响。然而,在ECM水凝胶中培养的细胞比在I型胶原水凝胶中培养的细胞表达paxillin高50-70%。ECM水凝胶的收缩因所使用的ECM类型而异。随后用不同密度的I型胶原(因此收缩)进行的实验显示,paxillin的表达与凝胶收缩量之间没有相关性,这表明ECM的一种成分是ECM水凝胶中paxillin表达的驱动因素。此外,另一种连接标记物XXII型胶原蛋白的表达模式与paxillin相似,但效应量较小。使用组织特异性ECM允许解构类似于肌肉-肌腱连接的细胞-基质相互作用,以研究肌腱连接特异性蛋白的表达。肌肉-肌腱连接处是肌肉-肌腱单元的重要特征;然而,尽管两种组织类型之间存在串扰,但在当前的研究中,这种连接往往被忽视。解构细胞-基质相互作用将为研究重要的连接特异性特征和标记提供机会,这些特征和标记应该包含在肌肉-肌腱单元的组织模型中,同时对自然连接有更深入的了解。本研究旨在为未来的方法提供信息,以设计一个更相关的多组织平台来研究肌肉-肌腱单元。
{"title":"Extracellular Matrix Hydrogels Promote Expression of Muscle-Tendon Junction Proteins.","authors":"Lewis S Gaffney,&nbsp;Zachary G Davis,&nbsp;Camilo Mora-Navarro,&nbsp;Matthew B Fisher,&nbsp;Donald O Freytes","doi":"10.1089/ten.TEA.2021.0070","DOIUrl":"https://doi.org/10.1089/ten.TEA.2021.0070","url":null,"abstract":"<p><p>Muscle and tendon injuries are prevalent and range from minor sprains and strains to traumatic, debilitating injuries. However, the interactions between these tissues during injury and recovery remain unclear. Three-dimensional tissue models that incorporate both tissues and a physiologically relevant junction between muscle and tendon may help understand how the two tissues interact. Here, we use tissue specific extracellular matrix (ECM) derived from muscle and tendon to determine how cells of each tissue interact with the microenvironment of the opposite tissue, resulting in junction-specific features. The ECM materials were derived from the Achilles tendon and gastrocnemius muscle, decellularized, and processed to form tissue-specific pre-hydrogel digests. The ECM materials were unique in respect to protein composition and included many types of ECM proteins, not just collagens. After digestion and gelation, ECM hydrogels had similar complex viscosities that were less than type I collagen hydrogels at the same concentration. C2C12 myoblasts and tendon fibroblasts were cultured in tissue-specific ECM conditioned media or encapsulated in tissue-specific ECM hydrogels to determine cell-matrix interactions and the effects on a muscle-tendon junction marker, paxillin. The ECM conditioned media had only a minor effect on the upregulation of paxillin in cells cultured in monolayer. However, cells cultured within ECM hydrogels had 50-70% higher paxillin expression than cells cultured in type I collagen hydrogels. Contraction of the ECM hydrogels varied by the type of ECM used. Subsequent experiments with a varying density of type I collagen (and thus contraction) showed no correlation between paxillin expression and the amount of gel contraction, suggesting that a constituent of the ECM was the driver of paxillin expression in the ECM hydrogels. In addition, another junction marker, type XXII collagen, had similar expression patterns as paxillin, with smaller effect sizes. Using tissue-specific ECM allowed for the de-construction of the cell-matrix interactions similar to muscle-tendon junctions to study the expression of myotendinous junction-specific proteins. Impact statement The muscle-tendon junction is an important feature of muscle-tendon units; however, despite crosstalk between the two tissue types, the junction is often overlooked in current research. Deconstructing the cell-matrix interactions will provide the opportunity to study significant junction-specific features and markers that should be included in tissue models of the muscle-tendon unit, while gaining a deeper understanding of the natural junction. This research aims at informing future methods to engineer a more relevant multi-tissue platform to study the muscle-tendon unit.</p>","PeriodicalId":23133,"journal":{"name":"Tissue Engineering Part A","volume":" ","pages":"270-282"},"PeriodicalIF":4.1,"publicationDate":"2022-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39297325","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 5
The Synovium of Human Osteoarthritic Joints Retains Its Chondrogenic Potential Irrespective of Age. 人类骨关节炎关节的滑膜保持其软骨形成的潜力,而与年龄无关。
IF 4.1 Pub Date : 2022-03-01 Epub Date: 2021-12-27 DOI: 10.1089/ten.TEA.2021.0105
Ernst B Hunziker, Nahoko Shintani, Miroslav Haspl, Kurt Lippuner, Esther Vögelin, Marius J B Keel

The autologous synovium is a potential tissue source for local induction of chondrogenesis by tissue engineering approaches to repair articular cartilage defects that occur in osteoarthritis. It was the aim of the present study to ascertain whether the aging of human osteoarthritic patients compromises the chondrogenic potential of their knee-joint synovium and the structural and metabolic stability of the transformed tissue. The patients were allocated to one of the following two age categories: 54-65 years and 66-86 years (n = 7-11 donors per time point and experimental group; total number of donors: 64). Synovial biopsies were induced in vitro to undergo chondrogenesis by exposure to bone morphogenetic protein-2 (BMP-2) alone, transforming growth factor-β1 (TGF-β1) alone, or a combination of the two growth factors, for up to 6 weeks. The differentiated explants were evaluated morphologically and morphometrically for the volume fraction of metachromasia (sulfated proteoglycans), immunohistochemically for type-II collagen, and for the gene expression levels of anabolic chondrogenic markers as well as catabolic factors by a real-time polymerase chain reaction analysis. Quantitative metachromasia revealed that chondrogenic differentiation of human synovial explants was induced to the greatest degree by either BMP-2 alone or the BMP-2/TGF-β1 combination, that is, to a comparable level with each of the two stimulation protocols and within both age categories. The BMP-2/TGF-β1combination protocol resulted in chondrocytes of a physiological size for normal human articular cartilage, unlike the BMP-2-alone stimulation that resulted in cell sizes of terminal hypertrophy. The stable gene expression levels of the anabolic chondrogenic markers confirmed the superiority of these two stimulation protocols and demonstrated the hyaline-like qualities of the generated cartilage matrix. The gene expression levels of the catabolic markers remained extremely low. The data also confirmed the usefulness of experimental in vitro studies with bovine synovial tissue as a paradigm for human synovial investigations. Our data reveal the chondrogenic potential of the human knee-joint synovium of osteoarthritic patients to be uncompromised by aging and catabolic processes. The potential of synovium-based clinical engineering (repair) of cartilage tissue using autologous synovium may thus not be reduced by the age of the human patient. Impact statement Our data reveal that in younger and older age groups alike, synovial explants from osteoarthritic joints can be equally well induced to undergo chondrogenesis in vitro; that is, the chondrogenic potential of the human synovium is not compromised by aging. These findings imply that the autologous synovium represents an adequate tissue source for the repair of articular cartilage in clinical practice by tissue engineering approaches in human patients suffering from osteoarthritis, independent of

自体滑膜是一种潜在的组织来源,通过组织工程方法局部诱导软骨形成,修复骨关节炎中发生的关节软骨缺损。本研究的目的是确定人类骨关节炎患者的衰老是否会损害其膝关节滑膜的成软骨潜能以及转化组织的结构和代谢稳定性。患者被分配到以下两个年龄组中的一个:54-65岁和66-86岁(每个时间点和实验组n = 7-11个供体;捐助者总数:64)。滑膜活检通过单独暴露于骨形态发生蛋白-2 (BMP-2)、单独暴露于转化生长因子-β1 (TGF-β1)或两种生长因子的组合,在体外诱导软骨形成长达6周。通过实时聚合酶链式反应分析,对分化后的外植体进行形态学和形态计量学评估,包括异色(硫酸化蛋白多糖)的体积分数、ii型胶原的免疫组织化学含量,以及合成代谢软骨标志物和分解代谢因子的基因表达水平。定量变色显示BMP-2单独或BMP-2/TGF-β1联合诱导人滑膜外植体软骨分化的程度最大,即两种刺激方案中的每一种都达到相当的水平,并且在两种年龄类别中。BMP-2/TGF-β1联合治疗方案导致正常人类关节软骨的软骨细胞具有生理大小,而单独刺激BMP-2导致细胞末端肥大。合成代谢软骨生成标志物的稳定基因表达水平证实了这两种刺激方案的优越性,并证明了生成的软骨基质具有透明样的特性。分解代谢标志物的基因表达水平仍然极低。这些数据也证实了牛滑膜组织体外实验研究作为人类滑膜研究范例的有效性。我们的数据显示,骨关节炎患者的膝关节滑膜的成软骨潜能不受衰老和分解代谢过程的影响。因此,使用自体滑膜进行基于滑膜的软骨组织临床工程(修复)的潜力可能不会因人类患者的年龄而降低。我们的数据显示,在年轻人和老年人中,来自骨关节炎关节的滑膜外植体同样可以在体外诱导进行软骨形成;也就是说,人类滑膜的成软骨潜能不受年龄的影响。这些发现表明,在临床实践中,通过组织工程方法,自体滑膜是骨关节炎患者关节软骨修复的足够组织来源,与患者的年龄无关。
{"title":"The Synovium of Human Osteoarthritic Joints Retains Its Chondrogenic Potential Irrespective of Age.","authors":"Ernst B Hunziker,&nbsp;Nahoko Shintani,&nbsp;Miroslav Haspl,&nbsp;Kurt Lippuner,&nbsp;Esther Vögelin,&nbsp;Marius J B Keel","doi":"10.1089/ten.TEA.2021.0105","DOIUrl":"https://doi.org/10.1089/ten.TEA.2021.0105","url":null,"abstract":"<p><p>The autologous synovium is a potential tissue source for local induction of chondrogenesis by tissue engineering approaches to repair articular cartilage defects that occur in osteoarthritis. It was the aim of the present study to ascertain whether the aging of human osteoarthritic patients compromises the chondrogenic potential of their knee-joint synovium and the structural and metabolic stability of the transformed tissue. The patients were allocated to one of the following two age categories: 54-65 years and 66-86 years (<i>n</i> = 7-11 donors per time point and experimental group; total number of donors: 64). Synovial biopsies were induced <i>in vitro</i> to undergo chondrogenesis by exposure to bone morphogenetic protein-2 (BMP-2) alone, transforming growth factor-β1 (TGF-β1) alone, or a combination of the two growth factors, for up to 6 weeks. The differentiated explants were evaluated morphologically and morphometrically for the volume fraction of metachromasia (sulfated proteoglycans), immunohistochemically for type-II collagen, and for the gene expression levels of anabolic chondrogenic markers as well as catabolic factors by a real-time polymerase chain reaction analysis. Quantitative metachromasia revealed that chondrogenic differentiation of human synovial explants was induced to the greatest degree by either BMP-2 alone or the BMP-2/TGF-β1 combination, that is, to a comparable level with each of the two stimulation protocols and within both age categories. The BMP-2/TGF-β1combination protocol resulted in chondrocytes of a physiological size for normal human articular cartilage, unlike the BMP-2-alone stimulation that resulted in cell sizes of terminal hypertrophy. The stable gene expression levels of the anabolic chondrogenic markers confirmed the superiority of these two stimulation protocols and demonstrated the hyaline-like qualities of the generated cartilage matrix. The gene expression levels of the catabolic markers remained extremely low. The data also confirmed the usefulness of experimental <i>in vitro</i> studies with bovine synovial tissue as a paradigm for human synovial investigations. Our data reveal the chondrogenic potential of the human knee-joint synovium of osteoarthritic patients to be uncompromised by aging and catabolic processes. The potential of synovium-based clinical engineering (repair) of cartilage tissue using autologous synovium may thus not be reduced by the age of the human patient. Impact statement Our data reveal that in younger and older age groups alike, synovial explants from osteoarthritic joints can be equally well induced to undergo chondrogenesis <i>in vitro</i>; that is, the chondrogenic potential of the human synovium is not compromised by aging. These findings imply that the autologous synovium represents an adequate tissue source for the repair of articular cartilage in clinical practice by tissue engineering approaches in human patients suffering from osteoarthritis, independent of","PeriodicalId":23133,"journal":{"name":"Tissue Engineering Part A","volume":" ","pages":"283-295"},"PeriodicalIF":4.1,"publicationDate":"2022-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39557402","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Modeling viral infection with tissue engineering: COVID-19 and the next outbreaks 用组织工程模拟病毒感染:新冠肺炎和下一次疫情
Pub Date : 2022-01-28 DOI: 10.1016/B978-0-12-824064-9.00015-0
A. Tatara
{"title":"Modeling viral infection with tissue engineering: COVID-19 and the next outbreaks","authors":"A. Tatara","doi":"10.1016/B978-0-12-824064-9.00015-0","DOIUrl":"https://doi.org/10.1016/B978-0-12-824064-9.00015-0","url":null,"abstract":"","PeriodicalId":23133,"journal":{"name":"Tissue Engineering Part A","volume":"1 1","pages":"647 - 667"},"PeriodicalIF":0.0,"publicationDate":"2022-01-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42521797","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Future of nanotechnology in tissue engineering 纳米技术在组织工程中的未来
Pub Date : 2022-01-01 DOI: 10.1016/b978-0-12-824064-9.00003-4
V. Vijayan, Gerardo Hernandez-Moreno, V. Thomas
{"title":"Future of nanotechnology in tissue engineering","authors":"V. Vijayan, Gerardo Hernandez-Moreno, V. Thomas","doi":"10.1016/b978-0-12-824064-9.00003-4","DOIUrl":"https://doi.org/10.1016/b978-0-12-824064-9.00003-4","url":null,"abstract":"","PeriodicalId":23133,"journal":{"name":"Tissue Engineering Part A","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"53910022","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Dental pulp tissue regeneration 牙髓组织再生
Pub Date : 2022-01-01 DOI: 10.1016/b978-0-12-824064-9.00005-8
I. J. de Souza Araújo, E. Münchow, S. Tootla, M. Bottino
{"title":"Dental pulp tissue regeneration","authors":"I. J. de Souza Araújo, E. Münchow, S. Tootla, M. Bottino","doi":"10.1016/b978-0-12-824064-9.00005-8","DOIUrl":"https://doi.org/10.1016/b978-0-12-824064-9.00005-8","url":null,"abstract":"","PeriodicalId":23133,"journal":{"name":"Tissue Engineering Part A","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"53910034","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Tissue regeneration: Fetal to adult transition 组织再生:胎儿到成人的转变
Pub Date : 2022-01-01 DOI: 10.1016/b978-0-12-824064-9.00020-4
Ajoy Aloysius
{"title":"Tissue regeneration: Fetal to adult transition","authors":"Ajoy Aloysius","doi":"10.1016/b978-0-12-824064-9.00020-4","DOIUrl":"https://doi.org/10.1016/b978-0-12-824064-9.00020-4","url":null,"abstract":"","PeriodicalId":23133,"journal":{"name":"Tissue Engineering Part A","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"53910657","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Biosensors in tissue engineering 组织工程中的生物传感器
Pub Date : 2022-01-01 DOI: 10.1016/b978-0-12-824064-9.00026-5
Yubin Zhou, Huizhi Chen, Lianxian Guo, Jianqiang Liu, Hui Zhou, Liyan Wang, H. S. Nanda, Xinsheng Peng
{"title":"Biosensors in tissue engineering","authors":"Yubin Zhou, Huizhi Chen, Lianxian Guo, Jianqiang Liu, Hui Zhou, Liyan Wang, H. S. Nanda, Xinsheng Peng","doi":"10.1016/b978-0-12-824064-9.00026-5","DOIUrl":"https://doi.org/10.1016/b978-0-12-824064-9.00026-5","url":null,"abstract":"","PeriodicalId":23133,"journal":{"name":"Tissue Engineering Part A","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"53910710","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Experiment-Based Validation of Corneal Lenticule Banking in a Health Authority-Licensed Facility. 在卫生当局许可的设施中角膜透镜体库的实验验证。
IF 4.1 Pub Date : 2022-01-01 Epub Date: 2021-08-24 DOI: 10.1089/ten.TEA.2021.0042
Andri K Riau, Kenny P Y Boey, Nur Zahirah Binte M Yusoff, Tze-Wei Goh, Gary H F Yam, Kin F Tang, Catherine S H Phua, Hui-Jun Chen, Yoke F Chiew, Yu-Chi Liu, Jodhbir S Mehta

With the expected rise in patients undergoing refractive lenticule extraction worldwide, the number of discarded corneal stromal lenticules will increase. Therefore, establishing a lenticule bank to collect, catalog, process, cryopreserve, and distribute the lenticules (for future therapeutic needs) could be advantageous. In this study, we validated the safety of lenticule banking that involved the collection of human lenticules from our eye clinic, transportation of the lenticules to a Singapore Ministry of Health-licensed lenticule bank, processing, and cryopreservation of the lenticules, which, after 3 months or, a longer term, 12 months, were retrieved and transported to our laboratory for implantation in rabbit corneas. The lenticule collection was approved by the SingHealth Centralised Institutional Review Board (CIRB). Both short-term and long-term cryopreserved lenticules, although not as transparent as fresh lenticules due to an altered collagen fibrillar packing, did not show any sign of rejection and cytotoxicity, and did not induce haze or neovascularization for 16 weeks even when antibiotic and steroidal administration were withdrawn after 8 weeks. The lenticular transparency progressively improved and was mostly clear after 4 weeks, the same period when we observed the stabilization of corneal hydration. We showed that the equalization of the collagen fibrillar packing of the lenticules with that of the host corneal stroma contributed to the lenticular haze clearance. Most importantly, no active wound healing and inflammatory reactions were seen after 16 weeks. Our study suggests that long-term lenticule banking is a feasible approach for the storage of stromal lenticules after refractive surgery. Impact statement Since 2011, close to 3 million refractive lenticule extraction procedures have been performed. The majority of the extracted lenticules are discarded. The lenticules could have been cryopreserved and retrieved at a later date for therapeutic or refractive applications. Therefore, establishing a lenticule bank to collect, catalog, process, cryopreserve, and distribute the lenticules could be advantageous. In this study, we simulated a lenticule banking service in a validated health authority-licensed facility and showed that long-term cryopreservation of the lenticules in the facility was safe and feasible in vivo.

随着世界范围内接受屈光性晶状体摘除术的患者数量的增加,丢弃的角膜基质晶状体数量将会增加。因此,建立一个囊泡库来收集、分类、处理、冷冻保存和分发囊泡(以备将来的治疗需要)可能是有利的。在这项研究中,我们验证了晶状体库的安全性,包括从我们的眼科诊所收集人类晶状体,将其运送到新加坡卫生部许可的晶状体库,对晶状体进行处理和冷冻保存,在3个月或更长时间(12个月)后,将其取出并运送到我们的实验室用于植入兔角膜。透镜体收集已由SingHealth中央机构审查委员会(CIRB)批准。短期和长期冷冻保存的小晶状体,虽然由于胶原纤维填充改变而不像新鲜的小晶状体那样透明,但在16周内没有表现出任何排斥反应和细胞毒性,即使在8周后停用抗生素和类固醇,也没有引起雾状或新生血管。晶状体透明度逐渐改善,并在4周后基本清晰,与我们观察到角膜水化稳定的时间相同。我们发现,与宿主角膜基质的胶原纤维堆积的平衡有助于清除透镜状薄雾。最重要的是,16周后未见创面主动愈合和炎症反应。我们的研究表明,长期的晶状体储存是屈光术后间质晶状体储存的可行方法。自2011年以来,已经进行了近300万例屈光透镜摘除手术。大部分提取出来的皮囊被丢弃。晶状体可以冷冻保存,并在以后用于治疗或屈光应用。因此,建立一个能够收集、编目、加工、低温保存和分发的囊泡库是非常有利的。在这项研究中,我们在一个经过验证的卫生当局许可的设施中模拟了透镜体银行服务,并证明了透镜体在该设施中的长期低温保存在体内是安全可行的。
{"title":"Experiment-Based Validation of Corneal Lenticule Banking in a Health Authority-Licensed Facility.","authors":"Andri K Riau,&nbsp;Kenny P Y Boey,&nbsp;Nur Zahirah Binte M Yusoff,&nbsp;Tze-Wei Goh,&nbsp;Gary H F Yam,&nbsp;Kin F Tang,&nbsp;Catherine S H Phua,&nbsp;Hui-Jun Chen,&nbsp;Yoke F Chiew,&nbsp;Yu-Chi Liu,&nbsp;Jodhbir S Mehta","doi":"10.1089/ten.TEA.2021.0042","DOIUrl":"https://doi.org/10.1089/ten.TEA.2021.0042","url":null,"abstract":"<p><p>With the expected rise in patients undergoing refractive lenticule extraction worldwide, the number of discarded corneal stromal lenticules will increase. Therefore, establishing a lenticule bank to collect, catalog, process, cryopreserve, and distribute the lenticules (for future therapeutic needs) could be advantageous. In this study, we validated the safety of lenticule banking that involved the collection of human lenticules from our eye clinic, transportation of the lenticules to a Singapore Ministry of Health-licensed lenticule bank, processing, and cryopreservation of the lenticules, which, after 3 months or, a longer term, 12 months, were retrieved and transported to our laboratory for implantation in rabbit corneas. The lenticule collection was approved by the SingHealth Centralised Institutional Review Board (CIRB). Both short-term and long-term cryopreserved lenticules, although not as transparent as fresh lenticules due to an altered collagen fibrillar packing, did not show any sign of rejection and cytotoxicity, and did not induce haze or neovascularization for 16 weeks even when antibiotic and steroidal administration were withdrawn after 8 weeks. The lenticular transparency progressively improved and was mostly clear after 4 weeks, the same period when we observed the stabilization of corneal hydration. We showed that the equalization of the collagen fibrillar packing of the lenticules with that of the host corneal stroma contributed to the lenticular haze clearance. Most importantly, no active wound healing and inflammatory reactions were seen after 16 weeks. Our study suggests that long-term lenticule banking is a feasible approach for the storage of stromal lenticules after refractive surgery. Impact statement Since 2011, close to 3 million refractive lenticule extraction procedures have been performed. The majority of the extracted lenticules are discarded. The lenticules could have been cryopreserved and retrieved at a later date for therapeutic or refractive applications. Therefore, establishing a lenticule bank to collect, catalog, process, cryopreserve, and distribute the lenticules could be advantageous. In this study, we simulated a lenticule banking service in a validated health authority-licensed facility and showed that long-term cryopreservation of the lenticules in the facility was safe and feasible <i>in vivo</i>.</p>","PeriodicalId":23133,"journal":{"name":"Tissue Engineering Part A","volume":" ","pages":"69-83"},"PeriodicalIF":4.1,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39237527","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 7
Oro-dental regeneration Oro-dental再生
Pub Date : 2022-01-01 DOI: 10.1016/b978-0-12-824064-9.00010-1
M. Jose, S. Arya, Finosh G. Thankam
{"title":"Oro-dental regeneration","authors":"M. Jose, S. Arya, Finosh G. Thankam","doi":"10.1016/b978-0-12-824064-9.00010-1","DOIUrl":"https://doi.org/10.1016/b978-0-12-824064-9.00010-1","url":null,"abstract":"","PeriodicalId":23133,"journal":{"name":"Tissue Engineering Part A","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"53909746","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Tissue Engineering Part A
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1